Opendata, web and dolomites

FreeATPOC SIGNED

Towards an instrument-free future of molecular diagnostics at the point-of-care

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FreeATPOC project word cloud

Explore the words cloud of the FreeATPOC project. It provides you a very rough idea of what is the project "FreeATPOC" about.

poc    temperature    patient    extremely    advantage    translation    models    former    primarily    slow    sophisticated    enzymatically    market    fastidiosa    resource    regulated    genetic    ambient    uv    failures    hiv    combines    gaining    simplicity    monitoring    newly    amplification    colorimetric    restriction    combined    free    enzymes    infrastructure    applicability    tissues    acids    swabs    polymerases    maintenance    predictive    poor    outbreaks    groups    disease    diagnostic    xylella    acid    heaters       amplified    diagnostics    pathogens    economic    final    lab    samples    quantitative    care    revolutionize    clinically    electricity    time    modules    instrument    demonstrated    sensitive    advantages    ing    global    utility    ultra    expand    started    smartphone    ligases    min    nucleic    big    instruments    divided    detection    generation    infectious    technologies    substantial    combination    plant    assay    immuno    spreading    interestingly    accompanied    disadvantage    influenza    point    adoption    takes    vision    paper    benefits    enzymatic    blood    societal    molecular    sensitivities    limited    complexity    kits    latter    human    tools   

Project "FreeATPOC" data sheet

The following table provides information about the project.

Coordinator
IDRYMA TECHNOLOGIAS KAI EREVNAS 

Organization address
address: N PLASTIRA STR 100
city: IRAKLEIO
postcode: 70013
website: www.forth.gr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Total cost 3˙052˙500 €
 EC max contribution 3˙052˙500 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) coordinator 1˙146˙250.00
2    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 640˙000.00
3    GNOSIS DATA ANALYSIS IDIOTIKI KEFALAIOUCHIKI ETAIREIA EL (HERAKLION) participant 515˙000.00
4    UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST UK (LONDON) participant 401˙250.00
5    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 350˙000.00

Map

 Project objective

Molecular diagnostics is still primarily a lab-based method. Emerging technologies for application at the point of care (POC) or need, i.e., where a patient or a sample is, have started gaining a big part of the molecular diagnostics market. Interestingly, available methods are divided in two groups: sophisticated instruments for ultra-sensitive temperature-regulated enzymatic amplification of nucleic acids and extremely simple paper-based immuno-diagnostic kits. Complexity, the main disadvantage of the former, results in their poor translation to several applications at the POC. Simplicity, often accompanied by failures, of the latter is the reason for their slow adoption even in resource limited areas. Our vision is an instrument-free approach that combines the advantages of both groups, i.e., a method that does not use heaters or modules that require electricity, infrastructure and maintenance, but, still, takes advantage of enzymatically-amplified nucleic acids detection. To achieve the above, novel diagnostic tools for genetic amplification based on ligases, polymerases and restriction enzymes operating at ambient temperature will be developed, combined with quantitative smartphone colorimetric/UV detection. The global applicability of the new approach will be demonstrated during infectious disease (Influenza and HIV) testing in human samples (blood and swabs) and plant pathogens (Xylella fastidiosa) in plant-tissues. In all cases, we aim for a time-to-result of less than 60 min, demonstrated sensitivities down to the clinically/field relevant values and a final cost in the order of $1 per assay. Combination of Free@POC concept with newly developed predictive models will expand its utility to monitoring disease outbreaks and their spreading. This new generation of instrument-free molecular diagnostics is expected to revolutionize nucleic acid analysis at the POC but also in applications beyond resulting in substantial societal as well as economic benefits.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FREEATPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FREEATPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

PAN (2020)

Development of a demonstrator for the Penetrating Particle Analyser (PAN) technology

Read More  

EggSorter (2019)

Device and method for automatized egg cell inspection and sorting

Read More